|Articles|February 9, 2022
- Pharmaceutical Executive-02-01-2022
- Volume 42
- Issue 2
Pharmaceutical Executive, February 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 4 years ago
As Change Continues, Are You Digitally Fit For the Future?almost 4 years ago
Ready for Pharma’s Next Chapteralmost 4 years ago
The Tech Perspective: Coordinating a Plan of Engagementalmost 4 years ago
The Importance of Culturally Inclusive and Relevant Marketingalmost 4 years ago
Messaging Makeoveralmost 4 years ago
Ethics of Antibioticsalmost 4 years ago
What’s Up in Biotech These Days? Not Much, Unfortunatelyalmost 4 years ago
Planning for Second to Market in Orphan Disease Spacealmost 4 years ago
AI and Analytics Appear Ready to Surge in Sales and Marketingalmost 4 years ago
It’s Time for Companies To See Employees as Full-Time PeopleNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
2
Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference
3
President Trump Asks Congress to Enact 'The Great Healthcare Plan:' Report
4
JP Morgan 2026: Regeneron Focusing on Broad Pipeline Development
5

